Division of Diabetes, Endocrinology, and Metabolism, Vanderbilt University Medical Center, Nashville, TN 37232, USA.
Department of Diagnostic Medicine, Dell Medical School, University of Texas at Austin, Austin, TX 78712, USA.
J Clin Endocrinol Metab. 2023 Sep 18;108(10):2699-2707. doi: 10.1210/clinem/dgad150.
Individuals with type 1 diabetes (T1D) have a smaller pancreas, but longitudinal changes in pancreas size and shape are unclear.
We monitored changes in pancreas size and shape after diagnosis with T1D.
We conducted a prospective cohort study at an academic medical center between 2014 and 2022.
Individuals with T1D (n = 91) or controls (n = 90) underwent magnetic resonance imaging (MRI) of the pancreas, including longitudinal MRI in 53 individuals with new-onset T1D.
Interventions included MRI and continuous glucose monitoring (CGM).
Pancreas size and shape were measured from MRI. For participants who used CGM, measures of glycemic variability were calculated.
On longitudinal imaging, pancreas volume and pancreas volume index normalized for body weight declined during the first year after diagnosis. Pancreas volume index continued to decline through the fifth year after diagnosis. A cross-sectional study of individuals with diabetes duration up to 60 years demonstrated that pancreas size in adults negatively correlated with age and disease duration, whereas pancreas volume and pancreas volume index remained stable in controls. Pancreas volume index correlated inversely with low blood glucose index, a measure of risk for hypoglycemia. Pancreas shape was altered in individuals with T1D and further diverged from controls over the first 5 years after diagnosis. Pancreas size and shape are altered in nondiabetic individuals at genetic risk for T1D. Combined pancreas size and shape analysis better distinguished the pancreas of individuals with T1D from controls than size alone.
Pancreas size declines most rapidly near the clinical diagnosis of T1D and continues to decline throughout adulthood. Declines in pancreas size are accompanied by changes in pancreas shape.
1 型糖尿病(T1D)患者的胰腺较小,但胰腺大小和形状的纵向变化尚不清楚。
我们监测了 T1D 诊断后胰腺大小和形状的变化。
我们在 2014 年至 2022 年期间在一家学术医疗中心进行了一项前瞻性队列研究。
91 例 T1D 患者(T1D 组)或 90 例健康对照(对照组)接受了胰腺磁共振成像(MRI)检查,其中 53 例新诊断的 T1D 患者进行了纵向 MRI 检查。
包括 MRI 和连续血糖监测(CGM)。
从 MRI 测量胰腺大小和形状。对于使用 CGM 的参与者,计算了血糖变异性的测量值。
在纵向成像中,胰腺体积和体重标准化的胰腺体积指数在诊断后第一年下降。在诊断后第五年,胰腺体积指数仍继续下降。对糖尿病病程长达 60 年的个体进行的横断面研究表明,成年人的胰腺大小与年龄和疾病持续时间呈负相关,而对照组的胰腺体积和胰腺体积指数保持稳定。胰腺体积指数与低血糖指数呈负相关,低血糖指数是低血糖风险的衡量指标。T1D 患者的胰腺形状发生改变,并且在诊断后最初的 5 年内与对照组进一步分化。在非糖尿病个体中,T1D 的遗传风险也改变了胰腺大小和形状。与仅大小分析相比,胰腺大小和形状的联合分析可以更好地区分 T1D 患者和对照组的胰腺。
胰腺大小在 T1D 的临床诊断附近下降最快,并在整个成年期持续下降。胰腺大小的下降伴随着胰腺形状的变化。